Developing models for cachexia and their implications in drug discovery.

about

Nutrition in cachexia: from bench to bedside.Transgenic Mouse Models of SV40-Induced Cancer.A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart.

P2860

Q36679436-1DC97813-70EA-40E0-A871-94CEEE0BEE3A Q38795316-A0BEBED0-56A8-400F-AC1B-79C2A6210C52 Q42745683-AB86C544-8583-4BFC-BD25-8B5EF03DC22A

P2860

Developing models for cachexia and their implications in drug discovery.

Item

http://www.wikidata.org/entity/Q38451282

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Developing models for cachexia and their implications in drug discovery.

@en

type

Item

label

Developing models for cachexia and their implications in drug discovery.

@en

prefLabel

Developing models for cachexia and their implications in drug discovery.

@en

P1476

Developing models for cachexia and their implications in drug discovery.

@en

P2093

Jochen Springer

http://www.w3.org/2001/XMLSchema#string

Masaaki Konishi

http://www.w3.org/2001/XMLSchema#string

Nicole Ebner

http://www.w3.org/2001/XMLSchema#string

P2860

The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats

Mitochondria as a therapeutic target in heart failure

mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass

Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics"

Cancer cachexia: impact, mechanisms and emerging treatments

Interleukin-6 and cachexia in ApcMin/+ mice

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease

Drug repositioning: identifying and developing new uses for existing drugs

Can the pharmaceutical industry reduce attrition rates?

Extracellular superoxide dismutase ameliorates skeletal muscle abnormalities, cachexia, and exercise intolerance in mice with congestive heart failure.

P304

743-752

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17460441.2015.1041914

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stefan D. Anker

Stephan von Haehling

P577

2015-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25927848

http://www.w3.org/2001/XMLSchema#string

Developing models for cachexia and their implications in drug discovery.

about

P2860

P2860

Developing models for cachexia and their implications in drug discovery.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698